Previously, in a decision criticized by medical authorities, the record only indicated the application of Pfizer Baby in children with some comorbidities
Almost one hundred days after the approval by the National Health Surveillance Agency (Anvis), or Ministry of Health expanded the eligible audience for the vaccine Pfizer Baby Against the COVID-19🇧🇷 Now all children from 6 months to 5 years (4 years, 11 months and 29 days) can receive a dose. Previously, the chart only recommended, in a decision criticized by medical authorities, the immunization of children diagnosed with some comorbidity.
The technical note, with signatures dating back to last Friday 23, not only certifies the safety and efficacy of the immunizer, but also recognizes the significant burden of the disease in this public, especially among the younger ones. “The risk of severe covid-19 cases is known to decrease as the age group decreases, however, the risk of exacerbation increases in children under 2, noting that this population had the incidence of SARS (Severe acute respiratory syndrome) from covid-19 and the mortality rate due to the disease is higher than the population aged 5 to 19″, reads the document.
The vaccination schedule is a primary series of three 0.2 ml doses. The first vaccines are given three weeks apart, followed by a third at least eight weeks later.
🇧🇷The best content in your email for free. Choose your favorite Terra newsletter. Click here!
Source: Terra
Ben Stock is a lifestyle journalist and author at Gossipify. He writes about topics such as health, wellness, travel, food and home decor. He provides practical advice and inspiration to improve well-being, keeps readers up to date with latest lifestyle news and trends, known for his engaging writing style, in-depth analysis and unique perspectives.
